Items where authors include "Fernandes, D."

Article

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology. ISSN 2213-8587

Tavabie, O.D., Abbott, J., Abeysekera, K.W. et al. (97 more authors) (2023) Defining characteristics and outcomes for patients with non-alcoholic fatty liver disease admitted to hospital with decompensated cirrhosis. Journal of Hepatology, 79 (4). e165-e167. ISSN 0168-8278

Tavabie, O.D., Abbott, J., Abeysekera, K.W.M. et al. (97 more authors) (2023) Regional variations in inpatient decompensated cirrhosis mortality may be associated with access to specialist care: results from a multicentre retrospective study. Frontline Gastroenterology. ISSN 2041-4137

Tavabie, O.D., Abeysekera, K.W.M., Brennan, P.N. et al. (291 more authors) (2023) Regional variation in characteristics of patients with decompensated cirrhosis admitted to hospitals in the UK. The Lancet Gastroenterology & Hepatology, 8 (7). pp. 604-606. ISSN 2468-1253

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet. ISSN 0140-6736